Related Experiment Videos
The gamma-hydroxybutyrate signalling system in brain: organization and functional implications
1Centre de Neurochimie, Laboratoire de Neurobiologie Moléculaire des Interactions Cellulaires, UPR 416 CNRS, Strasbourg, France. maitre@neurochem.u-strasbg.fr
Progress in Neurobiology
|February 1, 1997
Summary
gamma-Hydroxybutyrate (GHB) is a brain metabolite that regulates dopamine release and neuronal activity. Its unique signaling properties and potential therapeutic applications are highlighted, especially in pathological conditions.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- gamma-Hydroxybutyrate (GHB) is a naturally occurring metabolite of GABA found in the brain and peripheral organs.
- Neuronal depolarization releases GHB into the extracellular space in a calcium-dependent manner.
- GHB exhibits unique signaling properties within the central nervous system.
Purpose of the Study:
- To investigate the distribution and function of GHB receptors in the brain.
- To elucidate the mechanisms underlying GHB's effects on dopaminergic and hippocampal neurons.
- To explore the therapeutic potential of targeting GHB receptors in pathological conditions.
Main Methods:
- Electrophysiological recordings to assess neuronal responses to GHB.
- Pharmacological characterization using GHB receptor antagonists (e.g., NCS-382) and GABAB receptor antagonists.
- Administration of GHB to study its brain penetration and effects on neurotransmitter release.
- Analysis of cGMP and inositol phosphate turnover in response to GHB stimulation.
Main Results:
- GHB receptors are localized in specific brain regions, including dopaminergic structures, hippocampus, and cortex.
- GHB stimulation can induce hyperpolarization or depolarization in different brain areas, affecting dopamine release.
- GHB readily penetrates the blood-brain barrier, allowing for significant increases in brain concentrations.
- GHB's effects are partially mediated by GHB receptors and potentially GABAB receptors.
Conclusions:
- GHB acts as a signaling molecule with distinct receptor populations in the brain.
- The endogenous GHB system plays a role in regulating dopaminergic pathways.
- Targeting GHB receptors may offer therapeutic benefits for conditions involving altered GHB levels, such as hepatic failure and alcoholic intoxication.